Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2001 3
2002 7
2003 4
2004 2
2006 1
2007 2
2008 3
2009 4
2010 3
2011 3
2012 3
2014 2
2016 1
2017 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD; SPIRIT-P1 Study Group. Mease PJ, et al. Among authors: cuchacovich rs. Ann Rheum Dis. 2017 Jan;76(1):79-87. doi: 10.1136/annrheumdis-2016-209709. Epub 2016 Aug 23. Ann Rheum Dis. 2017. PMID: 27553214 Free PMC article. Clinical Trial.
Immunopathogenesis of vasculitis.
Cuchacovich R. Cuchacovich R. Curr Rheumatol Rep. 2002 Feb;4(1):9-17. doi: 10.1007/s11926-002-0018-9. Curr Rheumatol Rep. 2002. PMID: 11798977 Review.
Systemic vasculitis in childhood.
Gedalia A, Cuchacovich R. Gedalia A, et al. Among authors: cuchacovich r. Curr Rheumatol Rep. 2009 Dec;11(6):402-9. doi: 10.1007/s11926-009-0059-4. Curr Rheumatol Rep. 2009. PMID: 19922729 Review.
39 results